219 related articles for article (PubMed ID: 12651273)
1. Second-generation blood tests to detect erythropoietin abuse by athletes.
Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
[TBL] [Abstract][Full Text] [Related]
2. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
[TBL] [Abstract][Full Text] [Related]
3. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
Parisotto R; Ashenden MJ; Gore CJ; Sharpe K; Hopkins W; Hahn AG
Haematologica; 2003 Aug; 88(8):931-40. PubMed ID: 12935982
[TBL] [Abstract][Full Text] [Related]
4. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
[TBL] [Abstract][Full Text] [Related]
5. A third generation approach to detect erythropoietin abuse in athletes.
Sharpe K; Ashenden MJ; Schumacher YO
Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
[TBL] [Abstract][Full Text] [Related]
6. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
7. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
[TBL] [Abstract][Full Text] [Related]
8. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
9. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
11. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
[TBL] [Abstract][Full Text] [Related]
12. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
Ashenden MJ; Sharpe K; Schoch C; Schumacher YO
Haematologica; 2004 Aug; 89(8):1019-20. PubMed ID: 15339692
[TBL] [Abstract][Full Text] [Related]
13. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
[TBL] [Abstract][Full Text] [Related]
14. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.
Lasne F; Thioulouse J; Martin L; de Ceaurriz J
Electrophoresis; 2007 Jun; 28(12):1875-81. PubMed ID: 17503402
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
16. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
Robinson N; Saugy M; Mangin P
Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
[TBL] [Abstract][Full Text] [Related]
18. Applications and biomonitoring issues of recombinant erythropoietins for doping control.
Tsitsimpikou C; Kouretas D; Tsarouhas K; Fitch K; Spandidos DA; Tsatsakis A
Ther Drug Monit; 2011 Feb; 33(1):3-13. PubMed ID: 21099742
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes.
Varlet-Marie E; Gaudard A; Audran M; Gomeni R; Bressolle F
Int J Sports Med; 2003 May; 24(4):252-7. PubMed ID: 12784166
[TBL] [Abstract][Full Text] [Related]
20. Detection of autologous blood transfusions in athletes: a historical perspective.
Mørkeberg J
Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
